Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-156175

President and CEO gave up 889 shares (to pay taxes)

  • President and CEO acquired 2,925 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2016-12-18 Option exercise +2,925 874,908 D: show line 1 in the form
Walker Neal President and CEO 2016-12-18 Shares withheld for taxes −889 $31.25 $27,781 874,019 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Walker Neal President and CEO 2016-12-18 Option exercise · Restricted Stock Units −2,925 8,775 D: show line 3 in the form
Loading xslF345X03/doc4.xml…